Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zhaoj
    Junior Member
    • Jan 2010
    • 5

    #1

    Double band in ChIP-seq lib prep for Illumina

    I hope somebody can help me out here.

    I often get double band in ChIP-seq lib prep for Illumina platform. One peak is about 200bp, and additional peak around 260bp. This happens often, but not all the time, really annoying. Does any body have clues?

    Could it be bad RNAase or Proteinase K on treating the ChIP samples? Because a recent exp has one old sample working fine (single 200bp peak), but not the new sample.

    Or too much adaptor in the library prep?

    Thanks in advance for your help!

    Jh
  • mountainogre
    Junior Member
    • Apr 2010
    • 5

    #2
    Hi Jh,
    Did you make any progress solving this problem?
    I have just observed the same thing and i don't know why.
    Have you seen this blog post: http://dnasizing.com/?p=105

    Comment

    • zhaoj
      Junior Member
      • Jan 2010
      • 5

      #3
      Not yet, but suspect
      1. RNA leftover
      2. inappropriate ratio of adaptor to DNA
      Frustrated, but I do not see it everytime, hope there will be an answer.

      Good luck with your experiment!

      Comment

      • CC_seqanswers
        Member
        • Jan 2011
        • 30

        #4
        May I ask what sizing technique in your case?

        Originally posted by zhaoj View Post
        Not yet, but suspect
        1. RNA leftover
        2. inappropriate ratio of adaptor to DNA
        Frustrated, but I do not see it everytime, hope there will be an answer.

        Good luck with your experiment!

        Comment

        • zhaoj
          Junior Member
          • Jan 2010
          • 5

          #5
          I tried cutting out from agarose gel

          Comment

          • mountainogre
            Junior Member
            • Apr 2010
            • 5

            #6
            And in my cases I size select with the e-Gel system. I aimed for the 180-200bp range.
            My situation was similar to jH, in my experiment 2 from 8 libraries had the strange appearance of a stronger band around 260bp, whereas the Bioanalyzer showed appropriate 180bp band only for the other 6 samples.
            I suspect some problem with over-amplification, since the two libraries with the extra band were the ones with the most DNA at the beginning of the protocol.

            Comment

            • zhaoj
              Junior Member
              • Jan 2010
              • 5

              #7
              How much adaptor do you use in each reaction?
              I use 1ul of 10 times diluted from Illumina.

              Comment

              • mountainogre
                Junior Member
                • Apr 2010
                • 5

                #8
                I use the same. I should also mention that I am doing ChIPseq, not RNAseq, so things could be a little different.
                I think I will repeat the prep with less starting material and see if that solves the problem.
                In this case I used 13-15ng on ChIPPed DNA, I think i will try <10ng.

                Comment

                • pmiguel
                  Senior Member
                  • Aug 2008
                  • 2328

                  #9
                  All,
                  I think the extra peaks phenomenon can derive from a number of different sources. I listed ones that occurred to me here:

                  Bridged amplification &amp; clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)


                  One odd thing in this thread -- the idea that the slower migrating peak is the single stranded one seems contrary to my intuition. But, for Agilent chips I think it is the case. For details see:

                  Techniques and protocol discussions on sample preparation, library generation, methods and ideas

                  Techniques and protocol discussions on sample preparation, library generation, methods and ideas


                  I am just wondering are there resources that state this? The fact that the link upthread is implying that this is the case, suggests there must be. But I had not heard it previously.

                  --
                  Phillip

                  Comment

                  Latest Articles

                  Collapse

                  • SEQadmin2
                    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                    by SEQadmin2



                    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                    Despite this, “CRISPR helped turn genome editing from a specialized technique into
                    ...
                    Yesterday, 11:01 AM
                  • SEQadmin2
                    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                    by SEQadmin2


                    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                    The systematic characterization of the human proteome has
                    ...
                    07-20-2026, 11:48 AM
                  • SEQadmin2
                    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                    by SEQadmin2



                    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                    ...
                    07-09-2026, 11:10 AM

                  ad_right_rmr

                  Collapse

                  News

                  Collapse

                  Topics Statistics Last Post
                  Started by SEQadmin2, Yesterday, 02:55 AM
                  0 responses
                  9 views
                  0 reactions
                  Last Post SEQadmin2  
                  Started by SEQadmin2, 07-24-2026, 12:17 PM
                  0 responses
                  12 views
                  0 reactions
                  Last Post SEQadmin2  
                  Started by SEQadmin2, 07-23-2026, 11:41 AM
                  0 responses
                  12 views
                  0 reactions
                  Last Post SEQadmin2  
                  Started by SEQadmin2, 07-20-2026, 11:10 AM
                  0 responses
                  24 views
                  0 reactions
                  Last Post SEQadmin2  
                  Working...